Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunogen Inc (NQ: IMGN )

17.16 +1.41 (+8.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,926,774
Open 16.60
Bid (Size) 17.10 (1)
Ask (Size) 17.24 (6)
Prev. Close 15.75
Today's Range 16.30 - 17.34
52wk Range 3.095 - 17.34
Shares Outstanding 226,070,419
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Midcap Biotech Stock ImmunoGen is Shooting Higher Today: Here's Why
ImmunoGen Inc (NASDAQ: IMGN) announced updated  
Via Benzinga
Tesla, Adobe, Mission Produce And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones rising around 100 points on Friday. Here are some big stocks recording gains in today’s session. Braze, Inc. (NASDAQ: BRZE) shares climbed 20.4% to $ 40.82... 
Via Benzinga

Performance

YTD
+259.75%
+259.75%
1 Month
+25.90%
+25.90%
3 Month
+353.97%
+353.97%
6 Month
+233.85%
+233.85%
1 Year
+370.14%
+370.14%

More News

Read More
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
Via Investor's Business Daily
ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 Congress
From ImmunoGen Inc.
Via Business Wire
The Latest Analyst Ratings for Immunogen
Via Benzinga
Truist Securities Maintains Buy Rating for Immunogen: Here's What You Need To Know
Via Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
Via Investor's Business Daily
Midcap Biotech Stock ImmunoGen is Shooting Higher Today: Here's Why
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Day One Biopharmaceuticals, ImmunoGen And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer
From ImmunoGen Inc.
Via Business Wire
AI Boom Wanes In June: Nvidia Falls Under $1T As Benzinga Reviews May's Champions
Via Benzinga
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImmunoGen, Inc.
Via Business Wire
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations
Via FinancialNewsMedia
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare Conference
From ImmunoGen, Inc.
Via Business Wire
Stocks Stumble, Weekly Wins Still In Sight
Via Talk Markets
3 Biotech Stocks That Are Revolutionizing Healthcare in 2023
Via InvestorPlace
MarketBeat Week in Review – 5/8 - 5/12
Via MarketBeat
Topics Economy Electric Vehicles
Exposures Electric Vehicles Interest Rates
ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ImmunoGen, Inc.
Via Business Wire
ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting
From ImmunoGen, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results
Via MarketBeat
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
From ImmunoGen Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.